I was in college in the fall of 1982 when seven people in Chicago died from cyanide-laced Tylenol capsules. I remember the news coverage, the sudden paranoia around medicine cabinets, and the speed with which Johnson & Johnson responded. Forty-plus years later, I still remember it. That's not an accident.
Someone had pulled bottles off store shelves, injected the capsules with potassium cyanide, and returned them. The tampering happened long after the product left J&J's factory. Legally and logically, the company had an easy out. The FDA hadn't ordered a recall, and even the FBI recommended against a full nationwide pull, arguing the contamination appeared limited to the Chicago area. J&J could have contained the response, lawyered up, and waited.
Instead, CEO James Burke asked his team two questions: how do we protect the people, and how do we save the product? In that order. The company spent $100 million to recall 31 million bottles of Tylenol nationwide and relaunched two months later in tamper-proof packaging. Burke went on national television himself. J&J set up a consumer hotline, cooperated fully with investigators, and offered free replacement bottles to anyone who turned theirs in. Congress passed what became known as "the Tylenol bill," making product tampering a federal offense, and the FDA eventually required tamper-proof packaging across the entire OTC industry.
The business result is almost counterintuitive. Market share dropped from 35% to 7% immediately after the deaths. By mid-1983 it had climbed back to 30%, and reached 35% by year's end. Tylenol went on to outsell the next four leading painkillers combined. A crisis that could have killed the brand permanently instead cemented it.
Now contrast that with what happened 28 years later in the Gulf of Mexico.
When the Deepwater Horizon platform exploded on April 20, 2010, killing 11 workers and triggering the largest offshore oil spill in U.S. history, BP had no crisis management plan in place. It was as though the company assumed such a thing could not happen to them, so there was no point being ready for it. Ambiguous public communication underestimated the volume of the spill while overestimating the company's ability to plug the well, creating an image of incompetence, at best, and fraudulence, at worst.
Then their CEO opened his mouth. Tony Hayward, under enormous public and media pressure, said: "There's no one who wants this thing over more than I do. I'd like my life back." Eleven workers were dead. Thousands of Gulf Coast families had their livelihoods destroyed. Fifteen years later, BP has faced 390,000 lawsuits and shelled out $71 billion in damages and mitigation, with restoration efforts still incomplete.
Boeing's handling of the 737 MAX crashes is, if anything, worse, because the underlying problem was self-inflicted. Two 737 MAX aircraft crashed in October 2018 and March 2019, killing 346 people, and investigations revealed issues with the aircraft's automated flight control system and Boeing's safety practices. Rather than grounding the fleet immediately after the second crash, CEO Dennis Muilenburg appealed directly to President Trump about the safety of the aircraft as aviation authorities around the world were grounding the MAX. The formal public apology came 80 days after the second crash.
Both BP and Boeing eventually said the right things. Eventually. The problem is that "eventually" is a confession of institutional instinct, and the instinct in both cases was self-protection first, accountability a distant second.
There's a structural insight buried in these cases that goes beyond PR advice. Burke didn't navigate the Tylenol crisis well because he had a superior communications strategy. He navigated it well because J&J had a written corporate credo, developed decades earlier by former chairman Robert Wood Johnson, that explicitly ranked the company's obligations: consumers first, employees second, communities third, shareholders last. When the crisis hit, Burke didn't have to decide what the right thing was. He already knew. The framework had been built when the stakes were low and the thinking could be clear.
But a credo is only as good as the person holding it. As I wrote a few weeks ago, solid culture and principles can crumble fast under a leader who lacks the character to act on them when it costs something real. Burke had both. The credo gave him the framework; his character gave him the resolve to use it when $100 million was on the line and the FBI was telling him not to. That combination is rarer than it should be.
The Tylenol lesson isn't really about crisis communications. It's about whether your values are load-bearing before you need them to be.
The J&J recall didn't just recover market share; it changed an entire industry. Tamper-proof packaging on every medication bottle you've opened for the past four decades exists because of those 7 deaths in Chicago and one CEO who asked the right question first. That's a different category of outcome than survival. That's leadership that compounds.
Most readers under 50 weren't paying attention in 1982, or weren't born yet. But the structural dynamics, the instinct to minimize, wait, deflect, protect the brand while appearing to address the problem, those haven't changed at all. If anything they've gotten worse in an era when social media makes every gaffe permanent and every delay visible in real time.
Burke's choice looks obvious in retrospect. The right thing usually does. What made it possible was the full stack: a credo built before the crisis, a leader with the character to act on it when the cost was real, and a culture that had genuinely internalized both. The harder part to build in advance: stakeholders who demand all three and refuse to rationalize away any of them. Employees, boards, customers. The willingness to accept less is where the whole thing starts to unravel.